Search Results - "Callaghan MU"

Author Index.

Source: Haemophilia. Feb2021 Supplement S2, Vol. 27, p182-192. 11p.

Management of a twin pregnancy patient with Glanzmann thrombasthenia might be caused by a novel ITGA2B gene mutation (c.2822G>A): a case report and family investigation.

Authors: Liao, Xiangcheng Zhu, Ruikai Yang, Zhigang et al.

Source: Platelets. Dec2025, Vol. 36 Issue 1, p1-9. 9p.

Breaking barriers in haemophilia A care: One‐year real‐world experience with emicizumab prophylaxis at Civil Service Hospital, Kathmandu, Nepal.

Authors: Poudyal, Bishesh Sharma Bajracharya, Nikesh Paudel, Bishal et al.

Source: Haemophilia. Mar2025, Vol. 31 Issue 2, p328-330. 3p.

Expert opinion paper on the treatment of hemophilia A with emicizumab.

Authors: López-Jaime, Francisco-José Benítez, Olga Díaz Jordán, Bolívar Luis et al.

Source: Hematology. Dec2023, Vol. 28 Issue 1, p1-7. 7p.

Thromboembolism risk of Janus kinase inhibitors with concurrent oral contraceptive use: a global multicentre cohort study.

Authors: Levine, Jasmine Islam, Rahib K Mo, Lillian et al.

Source: Clinical & Experimental Dermatology. Aug2025, Vol. 50 Issue 8, p1682-1684. 3p.

Reduced doses of emicizumab achieve good efficacy: Results from a national‐wide multicentre real‐world study in China.

Authors: Xu, Yuan Wang, Ying Wu, Runhui et al.

Source: Haemophilia. Jul2024, Vol. 30 Issue 4, p959-969. 11p.

CB2 and TRPV1 receptors in inflammatory state of macrophages from sickle cell anemia pediatric/young adults.

Authors: Di Feo, Giuseppe Giliberti, Giulia Rana-Seyfert, Deeksha et al.

Source: Scientific Reports. 8/8/2025, Vol. 15 Issue 1, p1-16. 16p.

Retrospective analysis of 26 children with severe autoimmune hemolytic anemia treated with transfusions of red blood cells.

Authors: Tang, Xue Li, Xiaoqing Wang, Yang et al.

Source: Pediatric Hematology & Oncology. Aug2025, Vol. 42 Issue 5, p257-264. 8p.

Disease and treatment burden of patients with haemophilia entering the explorer6 non‐interventional study.

Authors: Windyga, Jerzy Apte, Shashikant Frei‐Jones, Melissa et al.

Source: European Journal of Haematology. Nov2024, Vol. 113 Issue 5, p631-640. 10p.

Blue toe syndrome, severe haemophilia A and emicizumab.

Authors: Cardoso, Patrícia Santos Resende da Silva, Camila Beatriz Pereira Gomes de Abreu, Eliabe Silva et al.

Source: Haemophilia. Jan2024, Vol. 30 Issue 1, p241-244. 4p.

Analysis of Quality of Life of Teenagers with Hemophilia in Pakistan.

Authors: Javed, Maryam Hamdan, Qurrat Ulain Azam, Usama et al.

Source: Journal of Rawalpindi Medical College. Mar2026, Vol. 30 Issue 1, p47-52. 6p.

Efficacy, safety and cost of emicizumab prophylaxis in haemophilia A patients with inhibitors: A nationwide observational study in Taiwan.

Authors: Shen, Ming‐Ching Chou, Sheng‐Chieh Chiou, Shyh‐Shin et al.

Source: Haemophilia. Nov2023, Vol. 29 Issue 6, p1499-1508. 10p.

Managing Severe Hemophilia A in Children: Pharmacotherapeutic Options.

Authors: Regling K Callaghan MU Sidonio R Jr

Source: Pediatric health, medicine and therapeutics [Pediatric Health Med Ther] 2022 Feb 15; Vol. 13, pp. 27-35. Date of Electronic Publication: 2022 Feb 15 (Print Publication: 2022).

Publication Type: Journal Article; Review

Journal Info: Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101655856 Publication Model: eCollection Cited Medium: Internet ISSN: 1179-9927 (Electronic) Linking ISSN: 11799927 NLM ISO Abbreviation: Pediatric Health Med Ther Subsets: PubMed not MEDLINE

Prophylaxis with emicizumab in children under 12 years old with haemophilia A without inhibitors in Uruguay: National experience.

Authors: Lemos, Felipe Petraccia, Carlos Fraga, María Laura et al.

Source: Haemophilia. Jul2024, Vol. 30 Issue 4, p1077-1079. 3p.

Real‐world data for the use of emicizumab in haemophilia A patients with inhibitors – First nationwide report from Korea.

Authors: Hahn, Seung Min Han, Jung Woo Kim, Jin Seok et al.

Source: Haemophilia. Jul2023, Vol. 29 Issue 4, p1163-1166. 4p. 1 Chart, 1 Graph.

Phosphatidate phosphatase Lipin1 alters mitochondria-associated endoplasmic reticulum membranes (MAMs) homeostasis: effects which contribute to the development of diabetic encephalopathy.

Authors: Huang, Shan Hua, Mengyu Liu, Wei et al.

Source: Journal of Neuroinflammation. 4/18/2025, Vol. 22 Issue 1, p1-22. 22p.

Bleeding control improves after switching to emicizumab: Real‐world experience of 177 children in the PedNet registry.

Authors: van der Zwet, Konrad de Kovel, Marloes Motwani, Jayashree et al.

Source: Haemophilia. May2024, Vol. 30 Issue 3, p685-692. 8p.

Unresolved hemostasis issues in haemophilia.

Authors: Sidonio, Robert F. Weisel, John W. Stafford, Darrel

Source: Haemophilia. 2024 Suppl 3, Vol. 30, p70-77. 8p.

Long‐term safety and efficacy outcomes of valoctocogene roxaparvovec gene transfer up to 6 years post‐treatment.

Authors: Symington, Emily Rangarajan, Savita Lester, Will et al.

Source: Haemophilia. Mar2024, Vol. 30 Issue 2, p320-330. 11p.

UKHCDO gene therapy taskforce: Guidance for implementation of haemophilia gene therapy into routine clinical practice for adults.

Authors: Chowdary, Pratima Duran, Beatriz Batty, Paul et al.

Source: Haemophilia. Jan2025, Vol. 31 Issue 1, p26-38. 13p.